Archive for » March, 2010 «

Wednesday, March 10th, 2010 | Author: Vision Shopsters

Technological innovations in the medical device industry have led to a radical transformation in patient care. This report identifies the sectors with the industry’s most important developments related to patient care, clinical outcomes, and new product development. While the scope of the report is limited to the top ten technologies only, it covers almost the entire medical device market.

Scientific and medical technology breakthroughs – such as minimally invasive surgery (MIS) – have accelerated the accuracy of clinical outcomes and have also reduced recovery times and the medical costs borne by patients. This has led to radical transformation in patient care.

IT integration in medical imaging and medical devices has given a significant boost to the healthcare industry, a trend that is apparent in the market growth of drug eluting stents and telemedicine technologies. The markets covered in the report have a current potential of $454.3 billion and are expected to grow at a CAGR of 9.8% between 2009 and 2014.

Market estimates and forecast
The report provides in-depth market estimates and forecast for top ten medical device technologies as follows:
• Diagnostic imaging (nuclear imaging, interventional radiology, capsule endoscopy and others)
• Drug delivery (needle free injections, transdermal systems, inhalation system, infusion system)
• Molecular diagnostics (biosensors, proteomics, nanotechnology, and others)
• Mobility aid technologies
• Minimal/non-invasive surgery (stents, bariatric surgery, medical robotics and others)
• Micro-fluids and MEMS (Miniature medical pressure sensors, bio chips, protein chips)
• Non-invasive monitoring (continuous blood glucose monitoring)
• Biomaterials (bionic limbs, joint replacement, antimicrobial wound dressing and others)
• Bio-implants (neurostimulation and others)
• Tele-medicines

Each section will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. This report will also provide more than 100 market tables for various geographic regions covering the sub-segments and micro-markets. In addition, the report also provides 50 company profiles for each of its sub-segments.

What makes our reports unique?
• We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 5.
• Each report is about 250 pages with 100+ market data tables, 40 competitive company profiles, analysis of 300 patents and minimum 50 micro markets, which are collectively exhaustive and mutually exclusive.
• No single report by any other publisher provides market data for all the segments viz products, services, applications, ingredients, technology, and stakeholders in a single report for all the four geographies – US, Europe, APAC, ROW.
• We provide 10% customization – Research shows that more than 40% of the times, clients do not get the specific intelligence they need in multi-client market research reports. We offer 10% customization in our reports at no extra cost. Get the exact market intelligence you require with real value for money.
• 15 pages of high level analysis including benchmarking strategies, best practices and the market’s cash cows (BCG matrix). We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.
• Comprehensive market analysis for pharmaceutical and biotech companies, medical device manufacturers, pharma-research labs, doctors, physicians and hospitals, medical/pharma associations, retailers and super-retailers, technology providers, and research and development (R&D) companies.

Key questions answered
• Which are the high-growth segments/cash cows and how is the market segmented in terms of applications, products, services, ingredients, technologies, and stakeholders?
• What are market estimates and forecasts; which markets are doing well and which are not?
• Where are the gaps and opportunities; what is driving the market?
• Which are the key playing fields? Which are the winning edge imperatives?
• How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?

Powerful Research and Analysis
The analysts working come from renowned publishers and market research firms, globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1124/Top-10-Medical-Device-Technology.html

Contact Us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

Wednesday, March 10th, 2010 | Author: Vision Shopsters

The global probiotics market is estimated to reach US$ 31.2 billion in 2014 growing at a CAGR of 11.7% from 2009 to 2014. In the year 2002, Food and Agriculture Organization (FAO) of the United Nations defined probiotics as ‘live microorganisms, which when administered in adequate amounts confer a health benefit on the host.’ Extensive research has opened up doors for the usage of probiotics, also highlighting its benefits including prevention and cure of certain diseases, such as inflammatory bowel disease, lactose intolerance. Its availability in the form of food and dietary supplements like dairy products and baked products has increased its consumption among the health-conscious population. One of the primary reasons behind the growth of the overall probiotics market is the improved efficiency of the ingredients that gives the products their bio-therapeutic properties. Probiotics and other similar products that promote health benefits have received a boost due to the increasing consumer demand for such products that prevent onset of digestive ailments and boost immune system. Ageing baby boomer population is one of the prime beneficiaries of probiotics followed by consumers of convenience and junk foods poor in fiber and nutrients since age and improper diet are two important factors responsible for the imbalance in the intestinal microbiota and the administration of probiotics helps to rectify the problem. Women being more health conscious and aware of probiotics than men, they are responsible for driving the market.

Foreseeing the rising importance of probiotics, several players have jumped into the bandwagon, producing innovative products and integrating probiotics with present products such as sausages, muffins, cheese, chocolates etc. However, the products have received varying level of success, in congruence with their overall health benefits. The highest number of product innovations has occurred in the field of probiotic functional foods and beverages (F&B) with more than 500 products of the latter category being introduced in the past decade. In this segment, probiotic dairy products have been enjoying the highest market share and are expected to continue to do so in the future; driven by their consistent demand and consumer perception that probiotic ingredients are most compatible and beneficial when integrated with dairy ingredients. The application of probiotics is found in regular consumption, for therapeutic use, prevention of diseases and also in animal feed for nutrition enhancement.

Market estimates and forecast

The report provides in-depth market estimates and forecast for global probiotics market as follows:
Products: Functional foods and beverages – dairy products, non dairy beverages, breakfast cereal, baked goods, fermented meat products, dry-food probiotics; animal feed probiotics; dietary supplements – food supplements, nutritional supplements and specialty nutrient.
Applications: Human application – regular consumption, probiotic therapy, prevention of diseases and probiotic application for animals.
Ingredients: Bacteria in probiotic foods – lactobacilli, bifidobacteria, bacillus coagulans; yeast and others.

Each section will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. This report will also provide more than 100 market tables for various geographic regions covering the sub-segments and micro-markets. In addition, the report also provides 40 company profiles for each of its sub-segments.

What makes our reports unique/ why you should buy this report?

• We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 5.
• Each report is about 250 pages with 100+ market data tables, 40 competitive company profiles, minimum 50 micro markets analyzed which are collectively exhaustive and mutually exclusive, 300 patents analyzed,
• No single report by any other publisher provides market data for all the segments viz products, services, applications, ingredients, technology, stakeholders in a single report for all the four geographies together- US, Europe, APAC, ROW.
• We provide 10% customization- normally it is researched that clients do not specific market intelligence what they are looking for. Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.
• 15 pages of high level analysis including benchmarking strategies, best practices and the market’s cash cows (BCG matrix). We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.
• Comprehensive market analysis for probiotics suppliers, probiotics product manufacturers, commercial research laboratories, dairy product manufacturers, confectionary product manufacturers, health supplement manufacturers, animal/poultry feed producers and biotechnology companies.

Key questions answered

• Which are the high growths segments/cash cows; how is the market segmented in terms of applications, products, ingredients, technologies, stakeholders.
• What are market estimates and forecast; which are markets are doing well and which are not?
- Where are the gaps and opportunities; what is driving the market;
- Which are the key playing fields? Which are the winning edge imperatives?
- How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strength and product pipelines? Who is doing what?

Powerful Research and analysis
The analyst working come from the renowned publishers and market research firms globally adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a database of hundred thousand of key industry participants and draw on our relationship with more than 900 market research companies globally. We are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1127/Probiotic-Market-Advanced-Technologies-and-Global-Market-2009-2014-.html

Contact Us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

Wednesday, March 10th, 2010 | Author: Vision Shopsters

http://www.visionshopsters.com/product/1134/Outsourcing-Opportunities-in-the-Medical-Device-2009-2014-.html

Medical devices form one of the largest industries in healthcare sector with an estimated size of $250 billion in 2009 and a growth rate of 6%-8%. The industry has been outsourcing medical device manufacturing services for almost a decade now. This trend has brought about huge profit margins, which has attracted many new players. Outsourcing has helped medical device manufacturers reduce product development cost by 10% to 30%. The services outsourcing industry has also gained from the entry of new medical device manufacturing companies, as these players lack experience in the field.

Orthopedic devices hold the largest market share and cardiology devices have the highest growth rate in the medical device manufacturing industry. The increasing regulations for class 2 and class 3 devices have increased the demand for regulatory consulting services. Growing complexities in supply chain and the need for efficient management of client accounts have increased the scope of product lifecycle management solution providers in the medical devices industry. Firms offering chip designing services have also benefitted from the increasing incidence of chronic diseases and the growing use of electronic and embedded systems in cardiovascular and neurology devices.

The report analyzes the outsourcing opportunities in cardiovascular, ophthalmic, oncology, dental, and neurology devices, along with a study of various tools used for developing, testing and simulation tools used for medical devices. The report categorizes the service outsourcing in medical device market as follows:

Services Market: Product design and development services, product testing and certification services, product implementation services, product maintenance services, product upgrade services and Regulatory consulting services for medical devices.

Applications Market: Class I Devices, Class II Devices and Class III Devices.

STAKEHOLDERS

The intended audience includes:

  • Service outsourcing companies
  • Medical devices manufacturers
  • Consulting companies
  • Financial institutions

What makes our reports unique?

  • We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 4.
  • Each report is about 250 pages with 100+ market data tables, 40 competitive company profiles, analysis of 200 patents and minimum 40 micro markets, which are collectively exhaustive and mutually exclusive.
  • No single report by any other publisher provides market data for all the segments viz products, services, applications, ingredients, technology, and stakeholders in a single report for all the four geographies – North America, Europe, Asia Pacific and ROW.
  • We provide 10% customization- normally it is seen that clients do not find specific market intelligence that they are looking for. Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.
  • 15 pages of high level analysis including benchmarking strategies, best practices (five level of products) and the market’s cash cows (BCG matrix). We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.

Key questions answered

  • Which are the high-growth segments/cash cows and how is the market segmented in terms of applications, products, services, ingredients, technologies, stakeholders?
  • What are market estimates and forecasts; which markets are doing well and which are not?
  • Where are the gaps and opportunities; what is driving the market?
  • Which are the key playing fields? Which are the winning edge imperatives?
  • How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?

Powerful Research and analysis

The analysts working come from renowned publishers and market research firms, globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1134/Outsourcing-Opportunities-in-the-Medical-Device-2009-2014-.html

Contact Us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

Wednesday, March 10th, 2010 | Author: Vision Shopsters

H1N1 Influenza A (2009) is the first pandemic influenza of 21st century affecting more than more than four lac people in more than 180 countries across the globe in 2009. The flu broke in Mexico in the month of March and then affected U.S. and after that it spread across the globe. H1N1 (2009) influenza have a mutation of pig, bird and humans which has made it more dangerous and fatal compared to previous occurrence of H1N1 (1918) http://www.visionshopsters.com/product/1129/Opportunity-Analysis-of-H1N1-swine-flu-Vaccination-Market.html.

The pandemic outbreak of the influenza opened the gates for the drugs such as Tamiflu in the initial phase for the curing of the disease but the following phase will see a shift from curing to prevention. Thus, arise the requirement for the vaccine for the treatment of H1N1. H1N1 vaccine market is the forecast for the upcoming vaccines for the prevention of the disease among the unaffected population. The vaccines market is classified for the intramuscular vaccines and intranasal vaccines. Intramuscular will cater 80-85% of market revenues and the remaining will be tapped by the intranasal vaccines. The initial lot of vaccines will be of egg based and cell based manufacturing. The market forecast is from late 2009 as the first lot of doses are expected to be rolled out in the first week of October 2009.

The first movers of the in the vaccines market are Glaxo Smith Kline (GSK), Novartis, CSL, Medimmune, Baxter, Sinovec and Sanofi Pastuer. Medimmune is the only producer of the intranasal vaccine whereas other companies are expected to come out with intramuscular vaccines. The companies have got approvals for their first lots from the governments of the various countries such as U.S., U.K., France, China, Denmark and Australia. The involvement of government bodies, increased awareness about prevention and pandemic situation of the influenza is driving the market for the vaccines.

Due to intensive ongoing research and technology introduction, the market players are compelled to understand the market dynamics, innovations, pricing, products, marketing and regulatory framework of the market.

The global H1N1 Influenza vaccine market is estimated to be of 676 million in 2009 with first lot of doses being commercialized on 30th September’ 2009. The market will see a high CAGR for the next two years i.e. the market is expected to be at $7.03 billion in 2011 with a CAGR of 222.4% from 2009 to 2011. However, the very high CAGR will settle down by 2012 to 30% for the period of 2009 to 2012. The reason for the sudden settle down of the growth is that it is expected that most of the world population will be immunized by the end of 2011.

Market estimates and forecast

This report will enable strategic understanding and opportunities in the H1N1 2009 influenza vaccines market. The report covers the following market segments.

Vaccines Markets: Intramuscular Vaccines and Intranasal vaccines.

Geography Markets: North America, Europe, Asia-Pacific and ROW

Each section of the report offers market data with respect to segments and geography. It also provides market trends with respect to drivers, restraints and opportunities. The report contains strategic section with respect to competitive landscape and market overview. The report will encompass around 15 company profiles

What makes our reports unique?

- We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 5.
- We provide 10% customization. Normally it is seen that clients do not find specific market intelligence that they are looking for. Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.
- We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.
- Comprehensive market analysis for the following sectors:
Pharmaceuticals, Medical Devices, Biotechnology, Semiconductor and Electronics, Energy and Power Supplies, Food and Beverages, Chemicals, Advanced Materials, Industrial Automation, and Telecom and IT. We also analyze retailers and super-retailers, technology providers, and research and development (R&D) companies.

Key questions answered

- Which are the high-growth segments/cash cows and how is the market segmented in terms of applications, products, services, ingredients, technologies, and stakeholders?
- What are market estimates and forecasts; which markets are doing well and which are not?
- Where are the gaps and opportunities; what is driving the market?
- Which are the key playing fields? Which are the winning edge imperatives?
- How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?

Powerful Research and analysis

The analysts working come from renowned publishers and market research firms, globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1129/Opportunity-Analysis-of-H1N1-swine-flu-Vaccination-Market.html

Contact Us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

Wednesday, March 10th, 2010 | Author: Vision Shopsters

The global market for neurostimulation products is expected to be worth $3.6 billion in 2009, growing at a CAGR of 22.7%, driven by the multiple treatment applications of neurostimulation products, and the emergence of venture capital in the industry.
Neurostimulation is used for the treatment of several debilitating conditions, including major treatment-resistant depression, epilepsy, gastroparesis, hearing loss, incontinence, chronic pain, Parkinson’s disease, and essential tremors. Neurostimulation systems provide an improved lifestyle alternative to many patients who do not obtain relief from standard drug and invasive surgical therapy.

The neurostimulation market is driven mainly by technology advancements, rising consumer awareness, rising age-related neurological disorders, improved clinical outcomes, long-term cost-effectiveness, increased FDA approvals for clinical trials, and the development of sophisticated implantable neurostimulation devices. Currently, there is a huge influx of new players entering into the market, thus leading to increased investments and R&D activities.

Implantable neurostimulation devices are increasingly being used for the treatment of a number of chronic disorders such as pain management and epilepsy. Manufacturers are employing developments in low-power semiconductor design, improved manufacturing procedures, and longer battery life for such devices to offer effective, efficient, and long-lasting neurostimulation products. Innovative products such as closed-loop system neurostimulator are designed to continuously stimulate the nervous system.

SCOPE AND FORMAT

The report analyzes the global biomarker market into the following segments:

• Product Market (spinal cord stimulator, deep brain stimulator, vagus nerve stimulator, sacral nerve stimulator, and gastric electrical stimulator )
• Application Market (Alzheimer’s, Parkinson’s, chronic heart failure, essential tremors, eye disorders, paralysis, obesity, and other medical conditions )
• Technology Market (minimally-invasive and non-invasive stimulation technology )

The market data consists of aggregate sales figures of all neurostimulation submarkets. It analyzes the market aspects of new neurostimulation technologies and product launches; sourcing key market developments from the top companies that it profiles. The report also analyzes the documented claims and the neurostimulation technology patents approved over the last five years to provide an in-depth understanding of neurostimulation product and applications.

What makes our report unique?

The existing studies and third-party market reports do not provide a comprehensive understanding of the neurostimulation market. The critical markets within this broader field are also not analyzed. This report gives a detailed analysis of the overall market as well as its most critical micro-markets, which have so far remained unexplored. In addition to the comprehensive information on the macro-markets, the report provides market data for up to five levels of the micro-markets under these identified macro markets. Other reports cover only the major technologies or products; and miss out subsequent micro levels.

Key questions answered

• Which are the high growth markets segments in terms of products, applications, and technology?
• What are the market forecasts and estimates from the period 2009-14?
• What are the major drivers and opportunities in the market?
• What is the competitive outlook, what are the major products and applications, who are the major players in the market segments?

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1119/Neurostimulation-Advanced-Technologies-and-Global-Market-2009-2014-.html

Contact Us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

Wednesday, March 10th, 2010 | Author: Vision Shopsters

Nanophotonics to Revolutionalize the Market (http://www.visionshopsters.com/product/1114/Nanophotonics-Advanced-Technologies-and-Global-Market-2009-2014-.html)

Nanophotonics is born out of the combination of three major sciences: photonics, nanotechnology, and optoelectronics. While photonics and optoelectronics have revolutionized the electronics and semiconductors market, nanotechnology has the greatest potential for further improvement, and hence has emerged as the most sought-after technology by big companies and research laboratories. In spite of it being in the nascent stage, nanophotonics is expected to make it to the mainstream market owing to its higher power efficiency, thermal resistivity, and operational life.

The nanophotonic component market is growing at a robust rate for the last few years and is expected to maintain a very high CAGR for the next few years. The market is expected to reach US$3.6 billion in 2014 at a CAGR of 100.7% from 2009 to 2014 and a similar growth pattern can be expected for the nanophotonics devices market as well. This market is expected to grow from a current market size of US$1.8 billion to US$58 billion in 2014.

Though most of the nanophotonic products are still under research, the available products such as nanophotonic LEDs, nanophotonic PV cells, nanophotonic OLEDs have been very successful in the market. Nanophotonic LEDs has the largest market share of US$106 million in 2009. However, considering the pace of progress in various other segments like near-field-optics, optical amplifiers, optical switches and holographic memory, it can be safely ascertained that holographic memory and optical switches are expected to have the highest growth rate in the next five years. Nanophotonic LEDs will still continue to be largest segment albeit with a slow growth rate.

In the nanophotonic LED market, the high beam LED has the highest market share followed by UV LED. In the fastest growing market of optical amplifiers, it is the optical fiber amplifier that commands the highest CAGR in the period 2009 to 2014 followed by semiconductor amplifiers. HDSS is also expected to grow with a CAGR comparable to that of optical amplifiers. OLED is estimated to be the slowest growing market. Lowering production costs and improving operational efficiencies would ensure opening of new opportunities for the nanophotonics market.

The market is very concentrated with only the market leaders like Osram, IBM, Samsung SDI, JDSU, etc doing extensive research in nanophotonics but as most of the application areas are related to electronics, this market is expected to attract a large number of players that would in turn increase the degree of competition.

Growth of Nanophotonic Products from 2009 – 2014

The graph indicates the forecasted growth rate of nanophotonics products from the year 2009 to 2014. The optical amplifiers are expected to grow at the maximum growth rate followed by the HDSS devices. The growth in the nanophotonics market is primarily due to the increasing demand from the Asian countries.

The key players in the nanophotonics component market are working at developing new products by forging strategic alliances with renowned universities, research laboratories and nanomaterial companies. These developments are focused on improving the operational parameters for the nanophotonic devices and grab the early mover’s advantages in the market.

Our patent analysis indicates that the U.S. has filed the highest number of patent applications in nanophotonics since 2006 followed by Europe. In the products category, nanophotonic LED accounts for the highest number of patents followed by nanostructures while OLED accounts for the lowest number.

What makes our reports unique?

We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 5.
Each report is about 250 pages with 100+ market data tables, 40 competitive company profiles, analysis of 300 patents and minimum 50 micro markets, which are collectively exhaustive and mutually exclusive.
No single report by any other publisher provides market data for all the segments viz products, services, applications, ingredients, technology, and stakeholders in a single report for all the four geographies – US, Europe, APAC, ROW.
We provide 10% customization- normally it is seen that clients do not find specific market intelligence that they are looking for. Our customization Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.
15 pages of high level analysis including benchmarking strategies, best practices and the market?s cash cows (BCG matrix). We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.
Comprehensive market analysis for pharmaceutical and biotech companies, medical device manufacturers, pharma-research labs, doctors, physicians and hospitals, medical/pharma associations, retailers and super-retailers, technology providers, and research and development (R&D) companies.
Key questions answered

Which are the high-growth segments/cash cows and how is the market segmented in terms of applications, products, services, ingredients, technologies, stakeholders?
What are market estimates and forecasts; which markets are doing well and which are not?
Where are the gaps and opportunities; what is driving the market?
Which are the key playing fields? Which are the winning edge imperatives?
How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?

Powerful Research and analysis

The analysts working come from renowned publishers and market research firms globally adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We, are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1114/Nanophotonics-Advanced-Technologies-and-Global-Market-2009-2014-.html

Contact Us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

Wednesday, March 10th, 2010 | Author: Vision Shopsters

The healthcare industry has recently witnessed the adoption of many new technologies that increase the efficiency of various medical treatments. Minimally invasive surgery (MIS) is one of the most important developments among all such cutting-edge medical technologies. This report uses the term ‘minimally invasive surgery’ to include non-invasive surgeries as well. The increasing demand of specialized treatment has propelled the market growth for MIS; and many companies – especially the new entrants from developing nations – are competing to benefit out of the rapid growth of this market.

With its progressive technological advancements such as capsule endoscopy and drug eluting stent, the MIS market is set to evolve due to the increasing demand for patient convenience, such as painless treatment and reduced post-operative stay. The MIS market has a current potential of $16.4 billion and is expected to grow at a CAGR of 8.3% between 2009 and 2014. The U.S. holds the major share of the global MIS market; and the growth of the U.S. market is driven by its growing ageing population and improvements in MIS technologies.

As the people are demanding more convenience such as painless treatment, and less post operative stay in surgeries, the market is set to evolve as a miniature instrument based surgery in the future, which will ensure further convenience in such type of surgeries. The introduction of capsule endoscopy is one such example. The minimal invasive surgery market is evolving towards more convenience for the patients and subsequent technological advancements. This showcases the growth potential of the miniature instruments based surgeries in future.
In 2009, the global minimal invasive/ non invasive market is estimated to be approximately $16.4 billion and is expected to reach $24.4 billion by 2014 at a CAGR of 8.3%.
Major driving factors for the minimal invasive/ non invasive surgery market
Increase in aging population (65 years and above) Increase in demand of less risky operating methods Pressure to reduce heath care cost Lesser hospitalization period compared to conventional surgeries Higher rate of acceptanceMajor restraints for the minimally invasive/ non invasive surgery market
Limited number of surgeries performed with minimally invasive technique Requirement of specialized training and equipments to perform such surgeriesMajor opportunities for the minimally invasive/ non invasive surgery market lies in its huge market size and growth which is driving new entrants in the market.

In the minimally invasive product market (which includes surgical devices, monitoring and visualization system, endosurgical equipments, medical robotics, and electrosurgical equipments), medical robotics is the fastest growing segment which is expected to reach $1.1 billion by 2014 growing at a CAGR of 21.3%, while surgical device alone constitute approximately $11.3 billion in 2009, which is more than 65% of the entire market.
In the minimally invasive application market (which includes gastrointestinal surgery, gynecology surgery, urology surgery, cosmetic surgery, obesity surgery, thoracic surgery, cardiac surgery, vascular surgery, orthopaedic surgery, and other surgery), cardiac surgery forms the major share of this market with estimated annual revenue of $11.2 billion in 2009. While orthopedic surgery is the highest growing market with a CAGR of 12.9% for the period 2009 to 2014 mainly due to introduction of new technologies such as joint replacements and bio implants in such surgeries.
The report covers the following markets and their subsequent micro markets as well in detail which includes their market size, forecast up to 2014, market drivers, restraints, competitive landscape, and issued patents.
Product (surgical devices, monitoring and visualization system, endosurgical equipments, medical robotics, and electrosurgical equipments) Application (gastrointestinal surgery, gynecology surgery, urology surgery, cosmetic surgery, obesity surgery, thoracic surgery, cardiac surgery, vascular surgery, orthopaedic surgery, and other surgery) Technology (Transcatheter surgery, laparoscopy surgery, non visual imaging and robotics) End user (Hospital surgical departments, outpatient surgery centers, group practices, individual surgeons, medical schools, and other users)

Market estimates and forecasts

The report provides in-depth market estimates and forecast for global minimally invasive/non-invasive market as follows:

• MIS market – products
Surgical devices, monitoring and visualization systems, endosurgical equipment, medical robotics, and electrosurgical equipment

• MIS market – application
Gastrointestinal surgery, gynecological surgery, urological surgery, cosmetic surgery, obesity surgery, thoracic surgery, cardiac surgery, vascular surgery, orthopaedic surgery, and other surgery

• MIS market – technology
Transcatheter surgery, laparoscopy, non-visual imaging, and medical robotics

• MIS market – end user
Hospital surgical departments, outpatient surgery centers, group practices, individual surgeons, medical schools, and other users

Each section will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. This report will also provide more than 100 market tables for various geographic regions covering the sub-segments and micro-markets. In addition, the report also provides 50 company profiles for each of its sub-segments.

What makes our reports unique?

• We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 5.
• Each report is about 250 pages with 100+ market data tables, 40 competitive company profiles, analysis of 300 patents and minimum 50 micro markets, which are collectively exhaustive and mutually exclusive.
• No single report by any other publisher provides market data for all the segments viz products, services, applications, ingredients, technology, and stakeholders in a single report for all the four geographies – US, Europe, APAC, ROW.
• We provide 10% customization – Research shows that more than 40% of the times, clients do not get the specific intelligence they need in multi-client market research reports. We offer 10% customization in our reports at no extra cost. Get the exact market intelligence you require with real value for money.
• 15 pages of high level analysis including benchmarking strategies, best practices and the market’s cash cows (BCG matrix). We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.
• Comprehensive market analysis for pharmaceutical and biotech companies, medical device manufacturers, pharma-research labs, doctors, physicians and hospitals, medical/pharma associations, retailers and super-retailers, technology providers, and research and development (R&D) companies.

Key questions answered

- Which are the high-growth segments/cash cows and how is the market segmented in terms of applications, products, services, ingredients, technologies, and stakeholders?
- What are market estimates and forecasts; which markets are doing well and which are not?
- Where are the gaps and opportunities; what is driving the market?
- Which are the key playing fields? Which are the winning edge imperatives?
- How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?

Powerful Research and analysis

The analysts working with MarketsandMarkets come from renowned publishers and market research firms, globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We, at MarketsandMarkets, are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1118/Minimally-Invasive-and-Non-Invasive-Product-and-Service-Market-2009-2014-.html


Contact Us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

Wednesday, March 10th, 2010 | Author: Vision Shopsters

Rising healthcare costs and the increasing demand for healthcare services have effected a significant transformation in the field of healthcare image management software over the last decade. Healthcare equipment vendors are now seeking to provide an integrated diagnostic model facilitating patient-centric, evidence-based healthcare. The major features of post-processing include workflow tasks such as image processing, image reconstruction, computer-aided detection, three-dimensional (3D) view generation, and quality control.

Digitalization of medical imaging over conventional film-based imaging has spurred the growth of the medical display market. Medical displays monitors play an important role in medical imaging process by enabling radiologists and surgeons to view and analyze the images generated by imaging modalities such as CT and MRI.

The global popularity of CAD software has also encouraged vendors to focus on niche-specific applications such breast CAD, thoracic CAD, and colon CAD. The breast CAD segment is expected to hold a strong position in the future due to the increasing number of MRI, mammo, and ultrasound CAD installations. However, the market still faces the challenges of expansion and of convincing the clinical community about the advantages of CAD in the detection and diagnosis of several types of carcinomas.

The global medical displays and post-processing software market is expected to reach a size of $2.5 billion by 2014, at a CAGR of 12.7% from 2009 to 2014. The software market is one of the most important segments and is expected to reach a market size of $1.3 billion by 2014 at a CAGR of 11%.

Market estimates and forecast

The report provides in-depth market estimates and forecast for medical displays such as referral and surgical displays; and for advanced visualization and post-processing software such as CAD and 3D.

What makes our reports unique?

•We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 5.
•We provide 10% customization. Normally it is seen that clients do not find specific market intelligence that they are looking for. Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.
•15 pages of high level analysis including benchmarking strategies, best practices and the market’s cash cows (BCG matrix). We conduct detailed market positioning, product positioning, and competitive positioning. Entry strategies, gaps, and opportunities are identified for all the stakeholders.

Powerful Research and Analysis
The analysts working with MarketsandMarkets come from renowned publishers and market research firms, globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We, at MarketsandMarkets, are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repositor

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1176/Medical-Imaging-Global-Displays-and-Post-Processing-Software-Market-2009-2014-.html

Contact Us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

Wednesday, March 10th, 2010 | Author: Vision Shopsters

Environmental concerns are driving the need for greener and efficient display systems with better image quality and lower power consumption. The advances in nanotechnology and optoelectronics resulted in the introduction of next-generation display products. The next-generation display market comprises of those displays that consume lesser power than CRT, LCD, and plasma technologies. This market is segmented into flexible, transparent, three-dimensional, midair, double-sided, touchscreen, and 2D one-sided displays. The basic technologies in all these displays are LED, OLED, FED, electroluminescent and field emissive display, electrochromic, electrophoretic and electrowetting displays http://www.visionshopsters.com/product/1113/Low-Power-Next-Generation-Display-Market-2009-2014-.html.

In 2008, the market size of next-generation display components was $6 billion that is expected to grow exponentially by 2014 because of the increasing use of the next generation display components in consumer electronics. This revenue potential highlights the immense opportunity in the next-generation display market.

Fragmentation and intense competition in the electronics industry has induced electronics manufacturers to improve upon the quality and reduce the prices of their products. Therefore, the expensive ingredients and large R&D investments required for next-generation displays act as a major restraint for the growth of this market. However, the evolution of the next-generation display market into a mainstream market is expected to overcome all these restraints.

Low labor cost and early initiatives have made Asia a dominant player in the next-generation display market, with a $3.7 billion or a 52% global market share in 2009. Asia’s large LED and OLED supplier-base also helps make the manufacture of these displays more cost-effective. Europe is expected to have the second-highest market for next-generation displays. The large consumer base of next-generation display devices in the U.S. and Europe makes them the most attractive markets for display components and device manufacturers.

Global Next-Generation Display Market by Products, 2009

In 2009, the market for 2D one-sided display is expected to dominate with a 72% market share, followed by the touchscreen display market with a share of 19%. The high market share of 2D one-sided display is mainly due to its low power consumption and its wide range of applications in industrial, advertising, entertainment, and consumer electronics sectors. The flexible display market is expected to grow at a high rate due to an increase in the demand for flexible, lightweight displays. 3D and midair display markets will have relatively smaller market shares but high growth rates due to the technical benefits they offer, such as uniform and stable 3D images.

Asia has the highest number of patents with a 39% share, closely followed by the U.S. with 35%. The increase in demand for lighter, thinner, efficient and low power consuming displays resulted in an increase in the number of patents filed in 2008 for LED, OLED and electrochromic displays.

The key players in this next-generation market include E-ink, RitDisplay, Samsung SDI, Sony, Toshiba, and Universal Display Corp.

Our analysis indicates that companies delivering improved and better performing next-generation display components will have an edge over their competitors. Agreements and collaborations as well as new product launches are some of the most popular strategies adopted by market players to stay ahead of competition and to expand into new geographies.

What makes our reports unique?

  1. We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 5.
  2. Each report is about 250 pages with 100+ market data tables, 40 competitive company profiles, analysis of 300 patents and minimum 50 micro markets, which are collectively exhaustive and mutually exclusive.
  3. No single report by any other publisher provides market data for all the segments viz products, services, applications, ingredients, technology, and stakeholders in a single report for all the four geographies – US, Europe, APAC, ROW.
  4. We provide 10% customization- normally it is seen that clients do not find specific market intelligence that they are looking for. Our customization Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.
  5. 15 pages of high level analysis including benchmarking strategies, best practices and the market?s cash cows (BCG matrix). We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.
  6. Comprehensive market analysis for pharmaceutical and biotech companies, medical device manufacturers, pharma-research labs, doctors, physicians and hospitals, medical/pharma associations, retailers and super-retailers, technology providers, and research and development (R&D) companies.

Key questions answered

  1. Which are the high-growth segments/cash cows and how is the market segmented in terms of applications, products, services, ingredients, technologies, stakeholders?
  2. What are market estimates and forecasts; which markets are doing well and which are not?
  3. Where are the gaps and opportunities; what is driving the market?
  4. Which are the key playing fields? Which are the winning edge imperatives?
  5. How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?

Powerful Research and analysis

The analysts working come from renowned publishers and market research firms globally adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1113/Low-Power-Next-Generation-Display-Market-2009-2014-.html

Contact Us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

Wednesday, March 10th, 2010 | Author: Vision Shopsters

Home healthcare, also referred to as formal or skilled care, is the support and care service that healthcare professionals provide at the patient’s own home. These care services include respiratory therapy, home infusion therapy, home medication, skilled nursing or medical care. The global home care and self care market is the aggregate of the markets for home healthcare equipment and home healthcare services.

The most important trend in healthcare witnessed in the recent times has been a shift of patient’s focus from hospitals to home care. The move from treatment to proactive monitoring has opened up new opportunities in the home healthcare market. Patients prefer home healthcare over hospitals mainly for the latter’s cost and convenience benefits; and are thus increasingly opting for third-party medical professionals and care-givers.

The home healthcare market generates approximately 70% of revenues from the people aged 65 years and above; mainly because of the declining ‘elderly support ratio’, or the ratio of the number of people caring for the elderly, to the number of older people above 65 years. This factor highlights the growth potential of the market for third-party care in the coming years.

Market Estimates and Forecast
The report provides in-depth market estimates and forecasts for the global home healthcare market as follows:

• Home Healthcare Equipment
o Home therapeutic equipment (oxygen delivery systems, CPAP, nebulizers, ventilators, humidifiers, IV diagnostics, home dialysis, ostomy supplies, and others)
o Home self diagnostics and patient monitoring equipment (diabetes care including blood glucose monitors, test strips, and insulin delivery devices; blood pressure monitors, holter monitors, heart rate meters, apnea and sleep monitors, and others)
o Mobility assist devices (wheelchairs, walkers, crutches, canes, walking sticks, examination chairs, treatment chairs, medical beds, ENT devices and other medical furniture and accessories)

• Home Healthcare Services
o Home respiratory therapy services
o Home infusion therapy services
o Home visits and nursing care services (physical examination, physical therapy, nursing services)
o Home telemedicine services

Each section will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. This report will also provide more than 100 market tables for various geographic regions covering the sub-segments and micro-markets. In addition, the report also provides 50 company profiles for each of its sub-segments.

What makes our reports unique?

- We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 5.
- Each report is about 250 pages with 100+ market data tables, 40 competitive company profiles, analysis of 300 patents and a minimum of 50 micro markets, which are collectively exhaustive and mutually exclusive.
- No single report by any other publisher provides market data for all the segments viz products, services, applications, ingredients, technology, and stakeholders in a single report for all the four geographies – US, Europe, APAC, ROW.
- We provide 10% customization. Research shows that more than 40% of the times, clients do not get the specific intelligence they need in multi-client market research reports. We offer 10% customization in our reports at no extra cost. Get the exact market intelligence you require with real value for money.
- 15 pages of high level analysis including benchmarking strategies, best practices and the market’s cash cows (BCG matrix). We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.
- Comprehensive market analysis for the following sectors:
Pharmaceuticals, Medical Devices, Biotechnology, Semiconductor and Electronics, Energy and Power Supplies, Food and Beverages, Chemicals, Advanced Materials, Industrial Automation, and Telecom and IT. We also analyze retailers and super-retailers, technology providers, and research and development (R&D) companies.

Key questions answered
- Which are the high-growth segments/cash cows and how is the market segmented in terms of applications, products, services, ingredients, technologies, and stakeholders?
- What are market estimates and forecasts; which markets are doing well and which are not?
- Where are the gaps and opportunities; what is driving the market?
- Which are the key playing fields? Which are the winning edge imperatives?
- How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?

Powerful Research and analysis
The analysts working come from renowned publishers and market research firms, globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We, at are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1138/Home-Healthcare-Market-2009-2014-updated.html

Contact Us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com